EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis

Dusan Harmacek, Lukas Weidmann, Kai Castrezana Lopez, Nicolas Schmid, Raphael Korach, Nicola Bortel, Seraina von Moos, Elena Rho, Birgit Helmchen, Ariana Gaspert, Thomas Schachtner

American Journal of Transplantation · 2024

DOI: 10.1016/j.ajt.2024.03.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2024. Verfasst von Dusan Harmacek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation, Isoantibodies, Tissue Donors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: USZ, Baugarten Foundation, Jubiläumsstiftung der Schweizerischen Lebensversicherungs- und Rentenanstalt für Volksgesundheit und medizinische Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biopsy-based transcript diagnostics may identify molecular antibody-mediated rejection (AMR) when microvascular inflammation (MVI) is absent. In this single-center cohort, biopsy-based transcript diagnostics were validated in 326 kidney allograft biopsies. A total of 71 histological AMR and 35 T cell-mediated rejection (TCMR) cases were identified as molecular AMR and TCMR in 55% and 63%, respectively. Among 121 cases without MVI (glomerulitis + peritubular capillaritis = 0), 45 (37%) donor-specific antibody (DSA)-positive and 76 (63%) DSA-negative cases were analyzed. Twenty-one out of the 121 (17%) cases showed borderline changes, or TCMR, while BK nephropathy was excluded. None of the 45 DSA-positive patients showed molecular AMR. Among 76 DSA-negative patients, 2 had mixed molecular AMR/TCMR. All-AMR phenotype scores (sum of R4-R6) exhibited median values of 0.13 and 0.12 for DSA-positive and DSA-negative patients, respectively (P = .84). A total of 13% (6/45) DSA-positive and 11% (8/76) DSA-negative patients showed an all-AMR phenotype score > 0.30 (P = .77). Patients with a higher all-AMR phenotype score showed 33% more histologic TCMR (P = .005). The median all-AMR phenotype scores of glomerular basement membrane double contours = 0 and glomerular basement membrane double contours > 0 biopsies were 0.12 and 0.10, respectively (P = .35). Biopsy-based transcript diagnostics did not identify molecular AMR in cases without MVI. Follow-up biopsies and outcome data should evaluate the clinical relevance of subthreshold molecular alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionKidney TransplantationIsoantibodiesTissue DonorsHumansMaleFemaleMiddle AgedFollow-Up StudiesPrognosisBiopsyAdultGlomerular Filtration RateGraft SurvivalInflammationRisk FactorsKidney Function TestsMicrovesselsRetrospective StudiesKidney Failure, ChronicHLA AntigensPostoperative Complications

Stichwörter der Autor:innen

Banff classificationantibody-mediated rejectionbiopsy-based transcript diagnosticskidney allograft injurymicrovascular inflammationrejection phenotype scores

Substanzen

IsoantibodiesHLA Antigens

Autor:innen und Institutionen

  • Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Division of Nephrology, University Hospital Zurich, Zurich, Switzerland. Electronic address: thomas.schachtner@usz.ch.

Förderung

  • USZ
  • Baugarten Foundation
  • Jubiläumsstiftung der Schweizerischen Lebensversicherungs- und Rentenanstalt für Volksgesundheit und medizinische Forschung

Zitieren

APA

Harmacek, D., Weidmann, L., Castrezana Lopez, K., Schmid, N., Korach, R., Bortel, N., von Moos, S., Rho, E., Helmchen, B., Gaspert, A., & Schachtner, T. (2024). Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.03.034

Vancouver

Harmacek D, Weidmann L, Castrezana Lopez K, Schmid N, Korach R, Bortel N, et al. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis. American Journal of Transplantation. 2024. doi:10.1016/j.ajt.2024.03.034

BibTeX
@article{Harmacek2024,
  author = {Harmacek, Dusan and Weidmann, Lukas and Castrezana Lopez, Kai and Schmid, Nicolas and Korach, Raphael and Bortel, Nicola and von Moos, Seraina and Rho, Elena and Helmchen, Birgit and Gaspert, Ariana and Schachtner, Thomas},
  title = {Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis},
  journal = {American Journal of Transplantation},
  year = {2024},
  doi = {10.1016/j.ajt.2024.03.034}
}
Kostenlos starten →